Osmotic diuresis by SGLT2 inhibition stimulates vasopressin‐induced water reabsorption to maintain body fluid volume-Reference-Cited by-同舟云学术

Osmotic diuresis by SGLT2 inhibition stimulates vasopressin‐induced water reabsorption to maintain body fluid volume

Published:2020-01 Issue:2 Volume:8 Page:
ISSN:2051-817X
Container-title:Physiological Reports
language:en
Short-container-title:Physiol Rep

Author:

Masuda Takahiro¹^ORCID,Muto Shigeaki¹,Fukuda Keiko¹,Watanabe Minami¹,Ohara Ken¹,Koepsell Hermann²,Vallon Volker³,Nagata Daisuke¹

Affiliation:

1. Division of Nephrology Department of Internal Medicine Jichi Medical University Shimotsuke Tochigi Japan

2. Department of Molecular Plant Physiology and Biophysics Julius‐von‐Sachs‐Institute of BiosciencesUniversity of Würzburg Würzburg Bavaria Germany

3. Division of Nephrology and Hypertension Department of Medicine and Pharmacology University of California San Diego &VA San Diego Healthcare System San Diego CA USA

Funder

Jichi Medical University

National Institutes of Health

Publisher

Wiley

Subject

Physiology (medical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.14814/phy2.14360

Reference60 articles.

1. Urinary excretion pattern of exosomal aquaporin-2 in rats that received gentamicin

2. AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus

3. Diuretic Effects of Sodium Glucose Cotransporter 2 Inhibitors and Their Influence on the Renin-Angiotensin System

4. Revised immunolocalization of the Na+-d-glucose cotransporter SGLT1 in rat organs with an improved antibody

5. How does salt retention raise blood pressure?

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits;Cellular Signalling;2024-10

2. The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-10

3. Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitor-Related Euglycemic Diabetic Ketoacidosis: A Case Series;Journal of Pharmacy Practice;2024-08-09

4. State-of-the-Art-Review: Mechanisms of Action of SGLT2 Inhibitors and Clinical Implications;American Journal of Hypertension;2024-07-17

5. Sodium glucose transporter 2 inhibitors: Will these drugs benefit non‐diabetic veterinary patients with cardiac and kidney diseases?;Journal of Veterinary Pharmacology and Therapeutics;2024-07-13